Microvesicle-containing miRNA-153-3p induces the apoptosis of proximal tubular epithelial cells and participates in renal interstitial fibrosis.
暂无分享,去创建一个
Y. Yang | W. Cao | J. Zhang | X-F Zhang | Zhang Xf | Yuejin Yang | Jinsong Zhang
[1] M. Gao,et al. LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[2] Y. Mu,et al. MicroRNA-153-3p enhances cell radiosensitivity by targeting BCL2 in human glioma , 2018, Biological Research.
[3] K. Satyamoorthy,et al. Clustered miRNAs and their role in biological functions and diseases , 2018, Biological reviews of the Cambridge Philosophical Society.
[4] Jing Wang,et al. Overexpression of MicroRNA-34a-5p Inhibits Proliferation and Promotes Apoptosis of Human Cervical Cancer Cells by Downregulation of Bcl-2. , 2018, Oncology research.
[5] Lu Cui,et al. Enhanced glycolysis in the process of renal fibrosis aggravated the development of chronic kidney disease. , 2018, European review for medical and pharmacological sciences.
[6] S. Tait,et al. Targeting BCL-2 regulated apoptosis in cancer , 2018, Open Biology.
[7] T. Whiteside. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment. , 2017, Seminars in immunology.
[8] W. Cao,et al. lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] Y. Zha,et al. Thymosin β4 alleviates renal fibrosis and tubular cell apoptosis through TGF-β pathway inhibition in UUO rat models , 2017, BMC Nephrology.
[10] M. L. Motti,et al. MicroRNAs, Cancer and Diet: Facts and New Exciting Perspectives. , 2017, Current molecular pharmacology.
[11] Hyoung-Tae Kim,et al. Degradation of Bcl-2 by XIAP and ARTS Promotes Apoptosis. , 2017, Cell reports.
[12] Sigrun Lange,et al. The emerging role of exosome and microvesicle‐ (EMV‐) based cancer therapeutics and immunotherapy , 2017, International journal of cancer.
[13] M. Guescini,et al. Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression. , 2017, Cancer research.
[14] M. Xie,et al. MicroRNA-148a promotes apoptosis and suppresses growth of breast cancer cells by targeting B-cell lymphoma 2 , 2017, Anti-cancer drugs.
[15] A. Benigni,et al. MicroRNAs as Master Regulators of Glomerular Function in Health and Disease. , 2017, Journal of the American Society of Nephrology : JASN.
[16] Yuan Tian,et al. Exosome separation using microfluidic systems: size‐based, immunoaffinity‐based and dynamic methodologies , 2017, Biotechnology journal.
[17] Yunchao Su,et al. Double knockout of Bax and Bak from kidney proximal tubules reduces unilateral urethral obstruction associated apoptosis and renal interstitial fibrosis , 2017, Scientific Reports.
[18] Zhiwei Ma,et al. miR-143 Induces the Apoptosis of Prostate Cancer LNCap Cells by Suppressing Bcl-2 Expression , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[19] R. Simpson,et al. Proteomic insights into extracellular vesicle biology – defining exosomes and shed microvesicles , 2017, Expert review of proteomics.
[20] J. Neuzil,et al. Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy , 2017, Experimental & Molecular Medicine.
[21] T. Masaki,et al. Klotho as a Therapeutic Target during the Development of Renal Fibrosis. , 2016, Contributions to nephrology.
[22] Y. B. Sun,et al. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis. , 2016, Differentiation; research in biological diversity.
[23] J. Chia,et al. CD39 overexpression does not attenuate renal fibrosis in the unilateral ureteric obstructive model of chronic kidney disease , 2016, Purinergic Signalling.
[24] P. Colman,et al. Targeting BCL-2-like Proteins to Kill Cancer Cells. , 2016, Trends in cancer.
[25] V. R. Josyula,et al. Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review , 2016, Artificial cells, nanomedicine, and biotechnology.
[26] Youhua Liu,et al. Renal fibrosis in 2015: Understanding the mechanisms of kidney fibrosis , 2016, Nature Reviews Nephrology.
[27] Elmar L. Gool,et al. Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles , 2016, Journal of thrombosis and haemostasis : JTH.
[28] H. Budak,et al. Plant miRNAs: biogenesis, organization and origins , 2015, Functional & Integrative Genomics.
[29] D. Fan,et al. MiRNAs in human cancers: the diagnostic and therapeutic implications. , 2014, Current pharmaceutical design.
[30] P. Zou,et al. [Research progress of mesenchymal stem cell-derived microvesicle]. , 2013, Zhongguo shi yan xue ye xue za zhi.
[31] Jiuyong Li,et al. Identifying miRNAs, targets and functions , 2012, Briefings Bioinform..
[32] Maria João Pires,et al. Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies. , 2017, In vivo.
[33] Hong-Jian Zhu,et al. Extracellular vesicles: their role in cancer biology and epithelial-mesenchymal transition. , 2017, The Biochemical journal.